Cord serum concentrations of IGF-I are increased in newborns of insulin-treated mothers (Type 1 diabetes [T1D] and Type 2 diabetes [T2D]) compared to nondiabetic controls [28]. The gene discussed is INS; the disease is type 2 diabetes mellitus.